Suppression of Peritoneal Fibrosis by Sonoporation of Hepatocyte Growth Factor Gene-Encoding Plasmid DNA in Mice

Gene therapy is expected to be used for the treatment of peritoneal fibrosis, which is a serious problem associated with long-term peritoneal dialysis. Hepatocyte growth factor (HGF) is a well-known anti-fibrotic gene. We developed an ultrasound and nanobubble-mediated (sonoporation) gene transfecti...

Descripción completa

Detalles Bibliográficos
Autores principales: Nishimura, Koyo, Ogawa, Koki, Kawaguchi, Maho, Fumoto, Shintaro, Mukai, Hidefumi, Kawakami, Shigeru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7829751/
https://www.ncbi.nlm.nih.gov/pubmed/33477422
http://dx.doi.org/10.3390/pharmaceutics13010115

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7829751/
https://www.ncbi.nlm.nih.gov/pubmed/33477422
http://dx.doi.org/10.3390/pharmaceutics13010115

Ejemplares similares